By understanding canonical mutated cancer cell signaling pathways (NF-κB, MAPK/ERK, JNK, PI3K, HIF, Wnt, VEGF) and the circRNAs that have been implicated in these pathways, new treatment methods and rationale can be developed for cancer therapy. This evidence concerns the gene NFKB1 and cancer.